Scleroderma Renal Crisis Debute with Thrombotic Microangiopathy: A Successful Case Treated with Eculizumab

Figure 5

This graphic shows the platelet count decrease at the beginning of the disease; that is the reason of suspect Thrombotic thrombocytopenic purpurea; we can see the ascending curve after day 19 with the start of Eculizumab therapy.